Home / Inspections / 1086315

FDA Inspection 1086315 — Central California Blood Center

Central California Blood Center — FEI 2970009

The FDA completed an inspection of Central California Blood Center on April 8, 2019 in Visalia, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 8, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Visalia, CA (United States)

Facility

Other inspections at this facility

  • 1231030 (NAI Wed Feb 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 999728 (NAI Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 926973 (NAI Mon May 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 829793 (NAI Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 728253 (NAI Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources